Skip to content
Catalyst

PapersPMID:34544493

Identification of the toxic threshold of 3-hydroxybutyrate-sodium supplementation in septic mice.

BMC pharmacology & toxicology2021The record ↗

  1. Finding, very limited evidenceno difference foundAll-cause mortality

No finding here moved its endpoint.

What did not

1 findingHow to read these marks →
  • “Severity of illness scores and mortality of septic mice receiving the reference dose of 150 mg 3HB-Na per day were comparable to those of septic mice receiving placebo.”
    Study
    animal · not in humans
    Duration
    5 days
    Dose studied
    D,L-3-hydroxybutyrate sodium salt 150 mg/day, twice-daily subcutaneous boluses, against isocaloric glucose placebo
    Population
    Male C57BL/6J mice with cecal ligation and puncture sepsis, centrally catheterised, fluid-resuscitated and on parenteral nutrition; reference dose 150 mg/day only

Study record

Design
animal study, in vivo
Species
animal
Population
24-week-old male C57BL/6J mice with cecal ligation and puncture sepsis on parenteral nutrition; D,L-3-hydroxybutyrate sodium (3HB-Na) by subcutaneous bolus
Participants
103
Comparator
another dose / placebo
Duration
5 days
Endpoints measured
30